Rosenblum-Mahaley Clinical Award
Rosenblum-Mahaley Clinical Award Recipients
AWARDS
| Year | AANS | CNS |
|---|---|---|
|
2024 |
David Puccio
The Genetic Profile Affects Survival in Breast Cancer Brain Metastasis Patients Treated by Stereotactic Radiosurgery |
Josepph Georges, DO, PhD
|
|
2023 |
Assaf Berger GRASP dynamic contrast-enhanced MRI can assist in distinguishing brain metastasis progression from radiation effects after stereotactic radiosurgery |
Ahmad Ozair Exceptional Responders to Base Excision Repair (BER) Inhibition for Recurrent Glioblastoma Display Enrichment for DNA Damage Response Pathways: RNA Sequencing Analysis from a Multicenter Trial |
|
2022 |
Andres Ramos-Fresnedo, Jeffrey Traylor
Survival Outcomes of Molecular Glioblastoma: A Multicenter Study |
Jeffrey Traylor
Evaluating Risk of Recurrence in Patients with Meningioma: Analysis of 703 Cases |
|
2021 |
Mohamad Bydon, MD, FAANS
Outcomes and Complications following Treatment for Sacral Chordoma: A Comparison between the United States Experience and Carbon Ion Radiation Therapy at the National Institutes for Quantum and Radiological Science & Technology |
Tito Vivas-Buitrago Supramarginal Resection Impact on Overall Survival for IDH-Wildtype Glioblastoma according to their Cell Density Distribution and Infiltration profile: A Mathematical Model. |
|
2020 |
Joseph Paul Antonios, MD Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial |
Fraser Henderson, MD Enhanced Fiber Tractography in Glioblastoma using a Novel Edema Correction Algorithm Correlated with Direct Intraoperative Electrical Stimulation and fMRI |
|
2019 |
Peter Nakaji Surgically Targeted Radiation Therapy: A Prospective Trial in 79 Recurrent, Previously Irradiated Intracranial Neoplasms |
Daniel A. Orringer
First in Human Phase I Trial of Dual Vector (HSV1-TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High-Grade Glioma: Initial Results |
|
2018 |
Ganesh Mani Shankar Genotype Based Local Targeted Therapy for Glioma |
Pascal O. Zinn Radiomic Machine Learning Algorithms Discriminate Pseudo-Progression from True Progression in Glioblastoma Patients: A Multi-Institutional Study |
|
2017 |
Matthew Garrett
Olig2 As a Novel Target for IDH1mutant Tumors |
Tareq Juratli
TERT Promoter Mutations in Progressive Treatment-resistant Meningiomas |
|
2016 |
John Sampson ReACT: A Randomized Phase II Study of Rindopepimut (CDX-110) plus Bevacizumab in Relapsed Glioblastoma |
Pascal Zinn Clinically Applicable and Biologically Validated MRI Radiomic Test Method Predicts Glioblastoma Genomic Landscape and Survival |
|
2015 |
Brian Nahed Circulating Tumor Cells in Glioblastoma Patients Demonstrate Mesenchmyal Expression |
Achal Singh Achrol Quantitative Volumetric MR Perfusion Identifies a Distinct Vasculogenic Molecular Subtype of Human Glioblastoma Associated with Worse Clinical Outcomes |
|
2014 |
Kristen A. Baitch Tetanus Toxoid Conditioning Enhances Migration and Efficacy of Dendritic Cell Vaccines in Patients with Glioblastoma |
Cleopatra Charalampaki Confocal Laser Endomicroscopy for Real Time Histomorphological Diagnosis: Our Clinical Experience with 150 Brain and Spinal Tumor Cases |
|
2013 |
Andrew Sloan |
Russell Lonser |
|
2012 |
Frederick Lang |
Ian F. Pollack |
|
2011 |
Zachary Litvack |
William T. Curry |
|
2010 |
Nader Sanai |
Mustafa Hatiboglu |
|
2009 |
Jeffrey Bruce |
Hideyuki Kano |
|
2008 |
Andrew Parsa |
Amy Heimberger |
|
2007 |
Stefan Kim |
Randy Jensen |
|
2006 |
Manish AghI |
David Mathieu |
|
2005 |
Ajay Jawahar |
John Yu |
|
2004 |
Ossama Al-Mefty |
Marvin Bergneider |
|
2003 |
Marcus L. Ware |
Franco DeMonte |
|
2002 |
Joung H. Lee |
Gene Barnett |
|
2001 |
Yutaka Sawamura |
Hae-Dong Jho |
|
2000 |
Robert Weil |
Ronald Warnick |
|
1999 |
Douglas Kondziokla |
Bruce Pollak |
|
1998 |
Prem Pillay |
Byron Young |
|
1997 |
Douglas Kondziokla |
Fred Barker |
|
1996 |
William Hitselberger |
Walter Hall |
|
1995 |
Wolfgang Koos |
Robert Selka |
|
1994 |
Shlomi Constantini |
Albino Bricolo |
|
1993 |
Georg Noren |
John Schneider |
|
1992 |
Robert Sanford |
Mark Bernstein |
|
1991 |
Not Given
|
James Melisi |
The Journal of Neuro-Oncology
Latest Newsletter
Upcoming Events
Latest Highlights in Neurosurgical oncology A Tumor Soirée 2.0: Complications, Innovations, and Case Lessons Saturday, May 2, 2026 | 7-11 pm Tower …
Latest Highlights in Neurosurgical oncology Tumor Wars II: Neuro-Onc Jeopardy — The Encore Sunday, May 3, 2026 | 5:45-6:45 pm Henry B. …
Latest Highlights in Neurosurgical oncology 19th Panhellenic Congress of the Hellenic Spine Society & 49th Symposium “N. Giannestras – P. Smyrnis” Friday, …
Share
Follow Us on X
Join us for the Second Tumor Soirée hosted by the @NSTumorSection at AANS San Antonio. An evening of insightful case discussions, networking and fine dining. Limited spots are available, sign up now! #AANS2026 #TumorSoiree https://invite.social/tumorsoiree2026
:
🧠 Cavernous sinus meningiomas = one of the toughest problems in neurosurgery
🔬 Operate? Radiate? Observe?
Learn from Dr. Jacques Morcos + expert panel
📅 April 8 | 3:30 PM CST
👇 Join here
https://rebrand.ly/q5mbl6t
#Neurosurgery #SkullBase #Meningioma #MedTwitter #AANS #CNS
🚨 Tumor Wars II: Neuro-Onc Jeopardy — The Encore 🧠⚡
📍 AANS 2026, San Antonio
📅 Sun, May 2 | 5:45–6:45 PM
Teams of med students, residents & fellows in a fast-paced neuro-onc Jeopardy battle
⚡ First come, first served — sign up now:
AANS 2026 NeuroOnc Jeopardy Sign-Up
Thank you for your interest in participating in the "NeuroOnc Jeopardy", happening on May 3rd, 2026 during the 202…
forms.gle
